• Content (Accesskey 0)
  • Navigation (Accesskey 1)
  • About us
  • Events
  • How to contact us
  • What's new
  • Accessibility
  • Legal notice
  • Privacy notice
DeutschEnglish
BASG
menu
  • Market Surveillance
    Official announcements
    • Messages in brief
    • Human medicines
    • Veterinary medicines
    • Blood & tissue
    • Medical devices
    • Illegal market
    Public registers
    • BASG “All-in-One Register”
    • Austrian Medicinal Product Index open_in_new
    • Medicine shortages catalogue open_in_new
    • Catalogue according to the regulation on ensuring the provision of medicinal products open_in_new
    • Pharmaceutical companies
    • Register of retailers
    • Internet pharmacies open_in_new
    • BASG official announcement open_in_new
    • BASG voting results open_in_new
    Reporting
    • Human adverse reaction notification
    • Veterinary Adverse Event Reports
    • Quality defects
    • Medicine shortages
    • National stockpiling
    • Illegal occurrences
    • Medical devices vigilance
    • Haemovigilance
    • Tissue vigilance
    • MedSafety Week 2023
    • MedSafety Week 2024
  • For Consumers
    Facts worth knowing about medicines
    • Medicinal products
    • Vaccines
    • Children and medicines
    • Administration of medicines
    • Package leaflet
    • Prescription/Non-prescription requirements
    • Ability to drive
    • Medication allergies
    • Doping
    • Expiry date and storage of medicines
    • Disposal of medicinal products
    • Useful Links
    Clinical Trials
    Medicines from the Internet
    • Online medicine retailers
    • Illegal websites
    Illegal market
    • Enforcement
    • Falsified medicines and medical devices
    • Serialisation and Verification
    • "Predatory publishers" and their effect
    • Glossary
    Medical devices
  • For Healthcare Professionals
    Safety information (DHPC)
    Clinical trials
    • Clinical trials of medicinal products
    • Clinical investigations with medical devices
    • Good Clinical Practice
    • Non-Interventional-Studies NIS
    • Compassionate use/Named Patient Use
    Blood safety
    • Authorisation and inspection of blood establishments
    Tissue safety
    • Certification, authorisation, and inspection of tissue establishments
    Medical Devices Operator
    Bringing into circulation
    • Mail order pharmacy
    • Self-assessment of pharmacies
    • Sampling
    Austrian Pharmacopoeia
    • Draft monographs for comments
    • Archive of monographs
    • Archive of deleted monographs
    CHMP Meeting Highlights-BASG
    • The CHMP introduces itself
  • For Companies
    Online services
    • Login online services open_in_new
    • Reporting adverse reactions open_in_new
    • Registration online services open_in_new
    • Contact
    • Veterinary Antimicrobial Consumption
    • Data provision medicine shortages
    • Antrag auf Infrastruktursicherungsbeitrag (ISB) - in German only
    • FAQ online Service
    • PHAROS user group
    • Terms for use
    Marketing authorisation & life-cycle
    • Marketing authorisation procedure
    • Austria as RMS
    • Electronic application
    • AGES eValidator
    • FAQ electronic Submission
    • Life-Cycle
    • Commission decisions
    • Forms for medicinal products
    • Change of ownership acc. to Art 25 AMG (human) or Art 16 TAMG (veterinary)
    • Veterinary medicinal products
    • FAQ marketing authorisation & life-cycle
    Pharmacovigilance
    • Pharmacovigilance inspection
    • PHV-wordings
    • Submission of Periodic Safety Update Reports (PSURs)
    • FAQ pharmacovigilance
    • Guideline pharmacovigilance
    Medicinal products
    • Scientific advice by BASG
    • Quality of medicines
    • Medicines for children
    • Orphan Medicinal Products
    • Plasma derived products
    • Batch release
    • Recombinant proteins
    • Forms for medicinal products
    • Controlled substances
    • Radiopharmaceuticals
    Import and export of medicines
    • Import of medicines
    • FAQ Import of medicinal products
    • Certificate for a Pharmaceutical Product (CPP)
    Medical devices
    • Manufacturer and representative
    • Importer and distributor
    • Medical devices fee
    • Free Sale Certificate - (FSC)
    • Notified Bodies
    Authorisation and certification
    • Good manufacturing / distribution practices (GMP/GDP)
    • Good Laboratory Practice (GLP)
    • Inspections of computer-aided systems
    Borderline products
    • Decisions of the AGBR
  1. Home
  2. Market Surveillance
  3. Official announcements
  4. Gabapentin
  • Official announcements
  • Messages in brief
  • Human medicines
  • Veterinary medicines
  • Blood & tissue
  • Medical devices
  • Illegal market

Gabapentin

PSUR-outcome | 07/12/2016

Related Files

  • attach_file
    Gabapentin | 117 KB

Related Links

  • link
    Gabapentin auf der Website der EMA.
Email

Further inquiry note

ase_phv@basg.gv.at
Page last modified: 09/09/2019
Back

For Companies

  • Marketing authorisation & Life-Cycle
  • Medical devices
  • Pharmacovigilance

Market Surveillance

  • Medicine shortage
  • Quality defects

For Healthcare Professionals

  • Safety information (DHPC)
  • Austrian Pharmacopoeia
  • Clinical trials

For Consumers

  • Medicinal products
  • Clinical trials
  • Medicines from the Internet
© 2025 Bundesamt für Sicherheit im Gesundheitswesen
  • Sitemap
  • Imprint
keyboard_arrow_up to top

Navigation

close
  • Market Surveillance »
    • Zurück
    • Market Surveillance
    • Official announcements »
      • Zurück
      • Official announcements
      • Messages in brief
      • Human medicines
      • Veterinary medicines
      • Blood & tissue
      • Medical devices
      • Illegal market
    • Public registers »
      • Zurück
      • Public registers
      • BASG “All-in-One Register”
      • Austrian Medicinal Product Index
        open_in_new
      • Medicine shortages catalogue
        open_in_new
      • Catalogue according to the regulation on ensuring the provision of medicinal products
        open_in_new
      • Pharmaceutical companies
      • Register of retailers
      • Internet pharmacies
        open_in_new
      • BASG official announcement
        open_in_new
      • BASG voting results
        open_in_new
    • Reporting »
      • Zurück
      • Reporting
      • Human adverse reaction notification
      • Veterinary Adverse Event Reports »
        • Zurück
        • Veterinary Adverse Event Reports
        • FAQ adverse events veterinary
        • Topical hormone replacement therapy: risks for pets
      • Quality defects
      • Medicine shortages
      • National stockpiling
      • Illegal occurrences
      • Medical devices vigilance
      • Haemovigilance
      • Tissue vigilance
      • MedSafety Week 2023
      • MedSafety Week 2024
  • For Consumers »
    • Zurück
    • For Consumers
    • Facts worth knowing about medicines »
      • Zurück
      • Facts worth knowing about medicines
      • Medicinal products »
        • Zurück
        • Medicinal products
        • Advanced therapy medicinal products
        • Classification guide for cell and tissue products
        • Generics
        • Biosimilars
        • Herbal medicinal products
        • Veterinary medicinal products
      • Vaccines »
        • Zurück
        • Vaccines
        • FAQ Vaccines
      • Children and medicines
      • Administration of medicines
      • Package leaflet »
        • Zurück
        • Package leaflet
        • Black triangle
        • Visually impaired patients
        • Off-Label Use
      • Prescription/Non-prescription requirements
      • Ability to drive
      • Medication allergies
      • Doping
      • Expiry date and storage of medicines
      • Disposal of medicinal products
      • Useful Links
    • Clinical Trials
    • Medicines from the Internet »
      • Zurück
      • Medicines from the Internet
      • Online medicine retailers »
        • Zurück
        • Online medicine retailers
        • FAQs - internet pharmacies
      • Illegal websites
    • Illegal market »
      • Zurück
      • Illegal market
      • Enforcement
      • Falsified medicines and medical devices
      • Serialisation and Verification
      • "Predatory publishers" and their effect
      • Glossary
    • Medical devices
  • For Healthcare Professionals »
    • Zurück
    • For Healthcare Professionals
    • Safety information (DHPC)
    • Clinical trials »
      • Zurück
      • Clinical trials
      • Clinical trials of medicinal products »
        • Zurück
        • Clinical trials of medicinal products
        • National rules and regulations
        • Recommendations for preparation for Reg (EU) 536/2014
        • Clinical Trials with Genetically Modified Organisms (GMOs)
      • Clinical investigations with medical devices
      • Good Clinical Practice
      • Non-Interventional-Studies NIS
      • Compassionate use/Named Patient Use
    • Blood safety »
      • Zurück
      • Blood safety
      • Authorisation and inspection of blood establishments
    • Tissue safety »
      • Zurück
      • Tissue safety
      • Certification, authorisation, and inspection of tissue establishments
    • Medical Devices Operator
    • Bringing into circulation »
      • Zurück
      • Bringing into circulation
      • Mail order pharmacy
      • Self-assessment of pharmacies
      • Sampling
    • Austrian Pharmacopoeia »
      • Zurück
      • Austrian Pharmacopoeia
      • Draft monographs for comments
      • Archive of monographs
      • Archive of deleted monographs
    • CHMP Meeting Highlights-BASG »
      • Zurück
      • CHMP Meeting Highlights-BASG
      • The CHMP introduces itself
  • For Companies »
    • Zurück
    • For Companies
    • Online services »
      • Zurück
      • Online services
      • Login online services
        open_in_new
      • Reporting adverse reactions
        open_in_new
      • Registration online services
        open_in_new
      • Contact
      • Veterinary Antimicrobial Consumption »
        • Zurück
        • Veterinary Antimicrobial Consumption
        • Provision of data
        • Extension DDDVet, DCDVet
        • FAQ antibiotics flow
      • Data provision medicine shortages
      • Antrag auf Infrastruktursicherungsbeitrag (ISB) - in German only
      • FAQ online Service »
        • Zurück
        • FAQ online Service
        • FAQ BASG-All-in-One Register
        • FAQ Registration
        • FAQ User rights
        • FAQ online services
        • FAQ Medicine shortages
        • FAQ National stockpiling
      • PHAROS user group
      • Terms for use »
        • Zurück
        • Terms for use
        • System requirements for electronic submission
    • Marketing authorisation & life-cycle »
      • Zurück
      • Marketing authorisation & life-cycle
      • Marketing authorisation procedure »
        • Zurück
        • Marketing authorisation procedure
        • Central Authorisation
        • MRP/DCP authorisation »
          • Zurück
          • MRP/DCP authorisation
          • Conditional Authorisation
          • Letter of Authorisation
          • MRP/DCP - national translations
          • Withdrawal during the authorisation procedure
        • National Authorisation
        • Registration in IRIS
        • Line Extension
        • Utilisation of genetic resources and traditional knowledge associated with genetic resources
        • Parallel import
        • Accessible patient information leaflet
        • Safety features AMVS
        • Classification and supply of substances under control »
          • Zurück
          • Classification and supply of substances under control
          • Prescription of medicines
      • Austria as RMS »
        • Zurück
        • Austria as RMS
        • DCP/MRP/RUP/SRP Slots
        • RMS transfer
        • RMS NEWS
      • Electronic application
      • AGES eValidator
      • FAQ electronic Submission
      • Life-Cycle
      • Commission decisions
      • Forms for medicinal products »
        • Zurück
        • Forms for medicinal products
        • National authorisation Life-Cycle forms
        • Sampling form for reference substances
      • Change of ownership acc. to Art 25 AMG (human) or Art 16 TAMG (veterinary)
      • Veterinary medicinal products »
        • Zurück
        • Veterinary medicinal products
        • Austria as RMS
          open_in_new
        • The EU veterinary medicinal products (VMP) regulation »
          • Zurück
          • The EU veterinary medicinal products (VMP) regulation
          • European guidelines
          • Application for Marketing Authorisation and Variations
          • Implementation of new QRD templates
          • Application acc. to Article 13 of Regulation (EU) 2019/6
          • SPC harmonisation
          • Clinical trials
          • Pharmacovigilance
          • Union Product Database (UPD) »
            • Zurück
            • Union Product Database (UPD)
            • Nomenclature of the texts
            • Organisation Management Service (OMS)
            • Submission of Annual Volume of Sales data
          • Notification of pet products
          • Herd-specific/Autologous vaccines
          • National Legislation / Information
        • Antimicrobial Consumption
          open_in_new
        • Contact
      • FAQ marketing authorisation & life-cycle »
        • Zurück
        • FAQ marketing authorisation & life-cycle
        • Application for variation »
          • Zurück
          • Application for variation
          • Variations to MRP and DCP authorisations
          • Variations to national authorisations
          • Approval Letter following Variation
          • End of Procedure date in case of Type IA/IAin Variations
          • Implementation date
        • BREXIT
        • Art. 5(3) referral on nitrosamines in human medicinal products
        • Austrian Medicinal Product Index
        • ATC/DDD Index 2025
        • ASMF - Active Substance Master File
        • Decisions - electronic delivery
        • Braille writing system
        • Batch release
        • CEP - Certification of suitability
        • Anti-doping warning
        • Elemental Impurities - ICHQ3D
        • Environmental Risk Assessment (ERA) »
          • Zurück
          • Environmental Risk Assessment (ERA)
          • ERA human
          • ERA veterinary
        • SmPC and PL
        • Accessible patient information leaflet
        • Homeopathic Medicinal Products
        • Annual fee
        • Medicines for children/Paediatric Worksharing
        • Mock-ups
        • Naming of medicinal products
        • Parallelimport
        • Herbal Medicinal Products
        • Black Triangle
        • Sunset clause
        • Renewal of marketing authorisation
        • Distributor in Austria
        • Authorisation/registration applications
        • Drug-Device Combinations
    • Pharmacovigilance »
      • Zurück
      • Pharmacovigilance
      • Pharmacovigilance inspection
      • PHV-wordings
      • Submission of Periodic Safety Update Reports (PSURs)
      • FAQ pharmacovigilance
      • Guideline pharmacovigilance
    • Medicinal products »
      • Zurück
      • Medicinal products
      • Scientific advice by BASG
      • Quality of medicines
      • Medicines for children
      • Orphan Medicinal Products
      • Plasma derived products
      • Batch release
      • Recombinant proteins
      • Forms for medicinal products »
        • Zurück
        • Forms for medicinal products
        • National authorisation and lifecycle forms
      • Controlled substances »
        • Zurück
        • Controlled substances
        • Forms
        • FAQ Controlled Substances
      • Radiopharmaceuticals
    • Import and export of medicines »
      • Zurück
      • Import and export of medicines
      • Import of medicines
      • FAQ Import of medicinal products
      • Certificate for a Pharmaceutical Product (CPP)
    • Medical devices »
      • Zurück
      • Medical devices
      • Manufacturer and representative
      • Importer and distributor
      • Medical devices fee
      • Free Sale Certificate - (FSC)
      • Notified Bodies
    • Authorisation and certification »
      • Zurück
      • Authorisation and certification
      • Good manufacturing / distribution practices (GMP/GDP) »
        • Zurück
        • Good manufacturing / distribution practices (GMP/GDP)
        • FAQ - GMP/GDP »
          • Zurück
          • FAQ - GMP/GDP
          • FAQ inspection procedure
          • FAQ Authorisation
          • FAQ Certificates
          • FAQ Storage/Transport
          • FAQ Medical sample
          • FAQ (hospital) pharmacies
          • FAQ Other
        • FAQ - reportable qualified persons
        • FAQ - human plasma for fractionation
      • Good Laboratory Practice (GLP) »
        • Zurück
        • Good Laboratory Practice (GLP)
        • FAQ - GLP
      • Inspections of computer-aided systems »
        • Zurück
        • Inspections of computer-aided systems
        • FAQ - Computer Aided Systems
    • Borderline products »
      • Zurück
      • Borderline products
      • Decisions of the AGBR
  • About us »
    • Zurück
    • About us
    • Vision, values and strategy
    • Tasks and Activities
    • Legal basis »
      • Zurück
      • Legal basis
      • Legal ordinances of BASG
    • BASG publications »
      • Zurück
      • BASG publications
      • BASG approval procedure »
        • Zurück
        • BASG approval procedure
        • BASG Protocols
      • BASG announcements
      • Rules of Procedure (in German only)
    • Fees »
      • Zurück
      • Fees
      • Official announcements
    • Quality Management
    • European Network
    • Scientific Board
    • Statistics »
      • Zurück
      • Statistics
      • Statistics on medicinal products
      • Statistics on reporting
      • Reports COVID-19 Vaccination
    • Publications »
      • Zurück
      • Publications
      • Annual Reports and Facts Folder
      • Folder
      • Scientific Publications
    • Official electronic signature
    • Press »
      • Zurück
      • Press
      • Photos
  • Events
    open_in_new
  • How to contact us
  • What's new »
    • Zurück
    • What's new
    • Registration and cancellation
    • RSS
  • Accessibility »
    • Zurück
    • Accessibility
    • Accessibility - reporting of side effects
    • Accessibility - BASG All-In-One Register
  • Legal notice
  • Privacy notice

Your privacy settings

We use cookies to adapt the website to your needs and to offer special features to you. By using our website, you agree to it.

Further information on cookies can be found in our Privacy policy.

Click on „Cookie-Preferences“ to change the cookie settings manually.

Your data protection settings

Enable and disable individual cookies. Required cookies cannot be disabled.

Required Cookies

  • Name Data protection cookie
    Provider BASG
    Privacy Policy https://www.basg.gv.at/datenschutzerklaerung
    Cookie supi
    Purpose Selected settings for cookies and embeded services.
    Expires after 7 to 30 days
  • Name TYPO3 cookies
    Provider TYPO3
    Privacy Policy https://www.basg.gv.at/datenschutzerklaerung
    Cookie fe_typo_user
    Purpose Stores information for website personalisation (eg. login)
    Expires after until session end
  • Name Load balancer session cookie
    Provider BASG
    Privacy Policy https://www.basg.gv.at/datenschutzerklaerung
    Cookie SERVERID
    Purpose Stores technical details for load balancing
    Expires after until session end

Marketing & Analytics

  • Name Matomo cookies
    Provider BASG
    Privacy Policy https://www.basg.gv.at/datenschutzerklaerung
    Cookie _pk_id
    Purpose Used to store a few details about the user such as the unique visitor ID
    Expires after 13 months
    Cookie _pk_ref
    Purpose Used to store the attribution information, the referrer initially used to visit the website
    Expires after 6 months
    Cookie _pk_ses
    Purpose Used to temporarily store data for the visit
    Expires after 30 minutes
    Cookie _pk_cvar
    Purpose Used to temporarily store data for the visit
    Expires after 30 minutes
    Cookie _pk_hsr
    Purpose Used to temporarily store data for the visit
    Expires after 30 minutes
    Cookie MATOMO_SESSID
    Purpose Used to temporarily store data for the visit
    Expires after until session end